About Roy Swiger
Form D filings for Acenxion Biosytems from 2023 to 2024 list Roy Swiger as CEO and director.
Roy Swiger first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Roy Swiger in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Roy Swiger works with at each company, as listed on that company's latest Form D.
Acenxion Biosytems, Inc. · Form D, Aug 14, 2024